![Jeffrey Ostrove](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Ostrove
Vorstandsvorsitzender bei Stelios Therapeutics, Inc.
Aktive Positionen von Jeffrey Ostrove
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | - | - |
Locanabio, Inc.
![]() Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 22.05.2019 | - |
Vorstandsvorsitzender | 22.05.2019 | 10.12.2019 | |
Stelios Therapeutics, Inc.
![]() Stelios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Lexeo Therapeutics, Inc., Stelios Therapeutics, Inc. is a company that develops novel adeno-associated virus based gene therapies for rare genetic cardiac conditions. The company is based in Cardiff, CA. The company was founded by Eric Adler and Farah Sheikh. The CEO is Jeffrey M. Ostrove. Stelios Therapeutics was acquired by Lexeo Therapeutics, Inc. on July 21, 2021. | Vorstandsvorsitzender | 01.12.2016 | - |
Finanzdirektor/CFO | - | - | |
Unternehmenssekretär | - | - | |
Paros Bio, Inc.
![]() Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a private company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. The company is focused on developing a gene replacement approach to treat autosomal dominant Alzheimer's disease (ADAD). Specifically, they are working on a gene therapy that targets mutations in the presenilin 1 gene (PSEN1), which is the underlying genetic cause of ADAD. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Jeffrey Ostrove
Ehemalige bekannte Positionen von Jeffrey Ostrove
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AbVitro LLC
![]() AbVitro LLC BiotechnologyHealth Technology AbVitro LLC provided an antibody discovery platform. The company was founded by George W. Church, Uri Laserson, Mirza Cifric and Francois Vigneault in 2010 and headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 23.10.2014 | 01.01.2016 |
Vorstandsvorsitzender | 23.10.2014 | 01.01.2016 | |
National Institute of Allergy & Infectious Diseases | Corporate Officer/Principal | - | - |
Magenta Corp.
![]() Magenta Corp. Industrial MachineryProducer Manufacturing Magenta Corp. manufactures plastic injection molds. The American company was founded by Jeffrey M. Ostrove. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Gründer | - | 29.01.2010 | |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Geschäftsführer | - | - |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Jeffrey Ostrove
University of Florida | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Operativ
Director/Board Member | 5 |
Chief Executive Officer | 4 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 6 |
Government | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 10 |
---|---|
Ceregene, Inc.
![]() Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Health Technology |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
AbVitro LLC
![]() AbVitro LLC BiotechnologyHealth Technology AbVitro LLC provided an antibody discovery platform. The company was founded by George W. Church, Uri Laserson, Mirza Cifric and Francois Vigneault in 2010 and headquartered in Seattle, WA. | Health Technology |
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Health Technology |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
National Institute of Allergy & Infectious Diseases | Government |
Magenta Corp.
![]() Magenta Corp. Industrial MachineryProducer Manufacturing Magenta Corp. manufactures plastic injection molds. The American company was founded by Jeffrey M. Ostrove. | Producer Manufacturing |
Locanabio, Inc.
![]() Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Technology Services |
Stelios Therapeutics, Inc.
![]() Stelios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Lexeo Therapeutics, Inc., Stelios Therapeutics, Inc. is a company that develops novel adeno-associated virus based gene therapies for rare genetic cardiac conditions. The company is based in Cardiff, CA. The company was founded by Eric Adler and Farah Sheikh. The CEO is Jeffrey M. Ostrove. Stelios Therapeutics was acquired by Lexeo Therapeutics, Inc. on July 21, 2021. | Health Technology |
Paros Bio, Inc.
![]() Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a private company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. The company is focused on developing a gene replacement approach to treat autosomal dominant Alzheimer's disease (ADAD). Specifically, they are working on a gene therapy that targets mutations in the presenilin 1 gene (PSEN1), which is the underlying genetic cause of ADAD. | Health Technology |
- Börse
- Insiders
- Jeffrey Ostrove
- Erfahrung